feedback

Activity Details

Free CME
1.0 AMA PRA Category 1 Credit(s)
Released: June 3, 2020
Expires: June 3, 2021
60 minutes to complete

Accredited By

Target Audience

This activity is intended for community pulmonologists, pulmonologists, rheumatologists, and other healthcare clinicians (MDs, PAs, and NPs) interested in treating patients with chronic fibrosing interstitial lung disease (CF-ILD).

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Identify patients with CF-ILD based on clinical, radiologic, and other features
  • Outline the steps of a comprehensive evaluation to ensure a diagnosis of CF-ILD
  • Evaluate pharmacologic and nonpharmacologic approaches to managing CF-ILD
  • Discuss the role of multidisciplinary collaboration in monitoring and managing CF-ILD

Activity Description

Immerse yourself in this interactive learning experience! This multi-faceted digital flipbook addresses the latest diagnostic and treatment strategies for patients with CF-ILD. Hear from Dr. Imre Noth, a leading Pulmonology expert on how to optimize diagnosis, treatment, monitoring, and multidisciplinary collaboration. Videos, charts, checklists, and sound bytes will be interspersed throughout the chapters to aid learning and discussion on difficult real-world patient cases as well as the definition and differentiation of CF-ILDs, CF-ILD pharmacotherapies, and supportive care. Bonus supplemental material about the potential impacts of COVID-19 on the disease course and management of patients with pulmonary fibrosis will also be included.

Statement of Educational Need

Clinicians have demonstrated a lack of understanding of identifying patients at risk for or with chronic fibrosing interstitial lung disease (CF-ILD), an umbrella term for multiple respiratory conditions associated with poor prognosis and limited treatment options. In addition, clinicians require education on CF-ILD pharmacologic and nonpharmacologic therapy. Clinicians need to also better understand the necessity and role of interdisciplinary collaboration when monitoring and managing CF-ILD. This activity will help learners overcome all of these aforementioned gaps to better ensure that their patients with CF-ILD receive appropriate care and achieve optimal outcomes.

Agenda

Flipbook highlights includes:

  • CF-ILD risk factors
  • Diagnosis of the various CF-ILD subtypes
  • Multidisciplinary CF-ILD identification and care strategies
  • CF-ILD pharmacotherapy safety and efficacy data
  • Supportive care and optimizing quality of life
  • Bonus material on CF-ILD and COVID-19

Faculty

Imre Noth, MD
Chief of Pulmonary & Critical Care Medicine
Professor of Medicine
University of Virginia School of Medicine
Charlottesville, VA


Conflict of Interest Policy/Disclosure Statement

The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME activity.

The following financial relationships have been provided:

Imre Noth, MD (Chair)
Consultant: Boehringer Ingelheim Pharmaceuticals and Genentech

Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: Nintedanib and Pirfenidone as well as other agents under investigation for ILD.

Accreditation Statement

The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation of Credit

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

(NOTE: Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.)

Instructions for Receiving Credit

This activity will take approximately 60 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 75% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.

Statement of Commercial Support

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals.

Disclaimer Statement/Disclosure of Unlabeled Use

The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.

This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

Contact Information for Questions About the Activity

For questions, contact Michelle Forcier at mforcier@achlcme.org

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.